[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 904
Citations 0
Editor's Note
July 2016

Simplification of Insulin Regimens in Patients With Type 2 Diabetes

JAMA Intern Med. 2016;176(7):1025. doi:10.1001/jamainternmed.2016.2298

In many patients with inadequately controlled type 2 diabetes, insulin is added to the treatment regimen. This often includes a daily dose of a long-acting insulin, as well as rapid-acting or short-acting insulin, sometimes with a sliding scale, to control elevated glucose following meals. Thus, treatment with insulin can impose a major burden, requiring patients to check blood glucose and inject insulin multiple times per day and to appropriately adjust insulin doses. The use of rapid-acting or short-acting insulin can also increase the risk for hypoglycemia, which is of particular concern in the elderly. In a research letter published in this issue of JAMA Internal Medicine,1 Munshi et al provide preliminary data to suggest that, compared with multiple doses of insulin, a single dose of basal insulin results in less hypoglycemia with little effect on glycated hemoglobin.

First Page Preview View Large
First page PDF preview
First page PDF preview